 Acute tumor lysis syndrome intrathecal methotrexate administration man acute tumor lysis syndrome single dose intrathecal methotrexate lymphomatous meningitis high-grade small B-cell setting untreated systemic disease metabolic derangements conservative therapy subsequent treatment Intrathecal methotrexate administration results toxic systemic methotrexate levels equivalent systemic dose Active central nervous system lymphoma duration toxic levels circulation contribute peripheral effects drug pathogenesis tumor lysis syndrome patient mechanisms systemic toxicity intrathecal methotrexate